马里引进疟疾疫苗,针对高风险季节,以提高成效。 Mali introduces malaria vaccine, targeting high-risk seasons to boost effectiveness.

马里已在其常规免疫方案中引入疟疾疫苗,成为这样做的第20个非洲国家。 Mali has introduced a malaria vaccine into its routine immunization program, becoming the 20th African country to do so. 疫苗采用混合方法,头三剂每月接种一次,第四和第五剂在疟疾高峰季节之前季节性地接种。 The vaccine uses a hybrid approach, with the first three doses given monthly and the fourth and fifth doses administered seasonally before the malaria peak season. 这项战略的目的是在风险最高时期最大限度地提高疫苗的效用。 This strategy aims to maximize vaccine effectiveness during the highest risk period. 马里的疟疾病例占全球疟疾病例的3.1%,死亡人数的2.4%,得到Gavi、儿童基金会和世卫组织的支持,得以展开防治工作。 Mali, with 3.1% of global malaria cases and 2.4% of deaths, received support from Gavi, UNICEF, and WHO for the rollout.